Animal External Medicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -…

Posted on by

New Jersey, United States,- Latest update on Animal External Medicine Market Analysis report published with extensive market research, Animal External Medicine Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Animal External Medicine industry. With the classified Animal External Medicine market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Animal External Medicine market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Animal External Medicine market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Animal External Medicine Market growth opportunities in the industry.

Animal External Medicine Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Animal External Medicine market size, volume and value, as well as price data.

Animal External Medicine Market competition by top Manufacturers:

Animal External Medicine Market Classification by Types:

Animal External Medicine Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Animal External Medicine Market Report:

Cataloging the competitive terrain of the Animal External Medicine market:

Unveiling the geographical penetration of the Animal External Medicine market:

The report of the Animal External Medicine market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Animal External Medicine Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Animal External Medicine Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read the original post:

Animal External Medicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -...

Aesthetic Medicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 – 3rd…

Posted on by

New Jersey, United States,- Latest update on Aesthetic Medicine Market Analysis report published with extensive market research, Aesthetic Medicine Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Aesthetic Medicine industry. With the classified Aesthetic Medicine market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Aesthetic Medicine market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Aesthetic Medicine market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Aesthetic Medicine Market growth opportunities in the industry.

Aesthetic Medicine Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Aesthetic Medicine market size, volume and value, as well as price data.

Aesthetic Medicine Market competition by top Manufacturers:

Aesthetic Medicine Market Classification by Types:

Aesthetic Medicine Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Aesthetic Medicine Market Report:

Cataloging the competitive terrain of the Aesthetic Medicine market:

Unveiling the geographical penetration of the Aesthetic Medicine market:

The report of the Aesthetic Medicine market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Aesthetic Medicine Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Aesthetic Medicine Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

More here:

Aesthetic Medicine Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 - 3rd...

Canine Stem Cell Therapy Market Report Provide the Development Strategies Adopted by Key Industry Players to Understand Competitive Scenario of the…

Posted on by

A new intelligence report Canine Stem Cell Therapy Market has been Lately Added into Adroit Market Research collection of top-line market research reports. Global Canine Stem Cell Therapy Market report is a meticulous comprehensive analysis of this market that provides access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual advice sourced from authentic industry pros and extensive main industry research, the report provides insights about the historical growth pattern of Canine Stem Cell Therapy Market and current market situation. It then provides short- and long-term market development projections.

Projections are purely based on the detailed analysis of key Market dynamics that are expected to influence Canine Stem Cell Therapy Market performance and their intensity of impacting market growth within the span of assessment period.

Request Sample Report @https://www.mrrse.com/sample/16152?source=atm

In addition to evaluation of dynamics, the report provides In-depth examination of key business trends that are expected to act more prominently in global Canine Stem Cell Therapy Market. The study also provides valued information about the present and upcoming growth opportunities in Canine Stem Cell Therapy Market the important players and new market entrants can capitalize on.

Competitive companies And manufacturers in global market

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type:

Application:

End User:

Region:

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/16152?source=atm

Opportunity assessment Provided in the Canine Stem Cell Therapy Market report Is important concerning understanding the profitable regions of investment, which are the technical insights for major market players, suppliers, vendors, and other stakeholders in Canine Stem Cell Therapy Market.

In-depth global Canine Stem Cell Therapy Market taxonomy presented in this Report offers detailed insights about each of the market sections and their sub-segments, which are categorized based on par various parameters. An exhaustive regional evaluation of global Canine Stem Cell Therapy Market divides international market landscape into essential geographies.

Regional outlook and country-wise evaluation of Canine Stem Cell Therapy Market Allows for the evaluation of multi-faceted performance of market in all the crucial markets. This advice plans to provide a wider scope of report to readers and identify the most relevant profitable areas in global market place.

Key Regions and Countries Covered in Global Canine Stem Cell Therapy Market Report-

Taxonomy and geographical analysis of the international Canine Stem Cell Therapy Market empowers readers to spot profits in present chances and catch upcoming growth opportunities even until they approach the market location. The analysis given in report is only intended to unroll the economic, societal, regulatory and political scenarios of the marketplace specific to each area and country, which might help prospective market entrants in Canine Stem Cell Therapy Market landscape to comprehend the nitty-gritty of target market regions and invent their strategies accordingly.

Buy This Report @ https://www.mrrse.com/checkout/16152?source=atm

Major TOC Covered In this Report are:

Originally posted here:

Canine Stem Cell Therapy Market Report Provide the Development Strategies Adopted by Key Industry Players to Understand Competitive Scenario of the...

Stem Cell And Regenerative Therapy Market : Segmentation, Industry Trends and Development size COVID-19 2024 – Kentucky Journal 24

Posted on by

he globalstem cell and regenerative medicines marketshould grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.

Report Scope:

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Request for Report Sample:https://www.trendsmarketresearch.com/report/sample/11723

Report Includes:

28 data tables An overview of global markets for stem cell and regenerative medicines Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024

Details of historic background and description of embryonic and adult stem cells Information on stem cell banking and stem cell research A look at the growing research & development activities in regenerative medicine Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. and Novartis AG

Summary

The global market for stem cell and regenerative medicines was valued at REDACTED billion in 2018. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED billion by 2024. Growth of the global market is attributed to the factors such as growingprevalence of cancer, technological advancement in product, growing adoption of novel therapeuticssuch as cell therapy, gene therapy in treatment of chronic diseases and increasing investment fromprivate players in cell-based therapies.

In the global market, North America held the highest market share in 2018. The Asia-Pacific region is anticipated to grow at the highest CAGR during the forecast period. The growing government funding for regenerative medicines in research institutes along with the growing number of clinical trials based on cell-based therapy and investment in R&D activities is expected to supplement the growth of the stem cell and regenerative market in Asia-Pacific region during the forecast period.

Reasons for Doing This Study

Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications. New advancement and product launches have influenced the stem cell and regenerative medicines market and it is expected to grow in the near future. The biopharmaceutical companies are investing significantly in cell-based therapeutics. The government organizations are funding research and development activities related to stem cell research. These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand of stem cell and regenerative therapy among different application segments. The market is impacted through adoption of stem cell therapy. The key players in the market are investing in development of innovative products. The stem cell therapy market is likely to grow during the forecast period owing to growing investment from private companies, increasing in regulatory approval of stem cell-based therapeutics for treatment of chronic diseases and growth in commercial applications of regenerative medicine.

Products based on stem cells do not yet form an established market, but unlike some other potential applications of bioscience, stem cell technology has already produced many significant products in important therapeutic areas. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its current practical applications, evaluate the participating companies and look to its future.

The report provides the reader with a background on stem cell and regenerative therapy, analyzes the current factors influencing the market, provides decision-makers the tools that inform decisions about expansion and penetration in this market.

More Info of ImpactCovid19@https://www.trendsmarketresearch.com/report/covid-19-analysis/11723

View original post here:

Stem Cell And Regenerative Therapy Market : Segmentation, Industry Trends and Development size COVID-19 2024 - Kentucky Journal 24

Growing Focus on Product Innovation Likely to Impact the Growth of the Animal Stem Cell Therapy Market 2017 2025 – Cole of Duty

Posted on by

A new intelligence report Animal Stem Cell Therapy Market has been recently added to Adroit Market Research collection of top-line market research reports. Global Animal Stem Cell Therapy Market report is a meticulous all-inclusive analysis of the market that offers access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual information sourced from authentic industry experts and extensive primary industry research, the report offers insights on the historic growth pattern of Animal Stem Cell Therapy Market and current market scenario. It then provides short- and long-term market growth projections.

Projections are purely based on the detailed analysis of key market dynamics that are expected to influence Animal Stem Cell Therapy Market performance and their intensity of impacting market growth over the course of assessment period.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/14941

In addition to evaluation of dynamics, the report provides in-depth examination of key industry trends that are expected to act more prominently in global Animal Stem Cell Therapy Market. The study also offers valued information about the existing and upcoming growth opportunities in Animal Stem Cell Therapy Market that the key players and new market entrants can capitalize on.

Competitive companies and manufacturers in global market

Key Participants

The key participants in the animal stem cell therapy market are Magellan Stem Cells, ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital and Clinic Frisco, CO, etc. The companies are entering into the collaboration and partnership to keep up the pace of the innovations.

The report covers exhaustive analysis on:

Regional analysis for Market includes

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/14941

Opportunity assessment offered in this Animal Stem Cell Therapy Market report is important in terms of understanding the lucrative areas of investment, which prove to be the actionable insights for leading market players, suppliers, distributors, and other stakeholders in Animal Stem Cell Therapy Market.

In-depth global Animal Stem Cell Therapy Market taxonomy presented in this report provides detailed insights about each of the market segments and their sub-segments, which are categorized based on t par various parameters. An exhaustive regional analysis of global Animal Stem Cell Therapy Market breaks down global market landscape into key geographies.

Regional outlook and country-wise analysis of Animal Stem Cell Therapy Market allows for the evaluation of multi-faceted performance of market in all the key economies. This information intends to offer a broader scope of report to readers and identify the most relevant profitable areas in global market place.

Key Regions and Countries Covered in Global Animal Stem Cell Therapy Market Report-

Taxonomy and geographical analysis of the global Animal Stem Cell Therapy Market enables readers to spot profits in existing opportunities and capture upcoming growth opportunities even before they approach the market place. The analysis offered in report is purely intended to unroll the economic, social, regulatory and political scenarios of the market specific to each region and country, which could help potential market entrants in Animal Stem Cell Therapy Market landscape to understand the nitty-gritty of target market areas and devise their strategies accordingly.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/14941

Animal Stem Cell Therapy Market Table of Contents

Read the rest here:

Growing Focus on Product Innovation Likely to Impact the Growth of the Animal Stem Cell Therapy Market 2017 2025 - Cole of Duty

Stem Cell Therapy Market Size By Types, By Application, By Region, And Forecast 20202027 – Owned

Posted on by

New Jersey, United States,- The Stem Cell Therapy Market report upholds the future market predictions related to Stem Cell Therapy market size, revenue, production, Consumption, gross margin, and other substantial factors. It also examines the role of the prominent Stem Cell Therapy market players involved in the industry including their corporate overview. While emphasizing the key driving factors for the Stem Cell Therapy market, the report also offers a full study of the future trends and developments of the market.

The recently documented report on the Stem Cell Therapy market is a detailed analysis of this business landscape and contains important details regarding the present market trends, current revenue, market size, industry share, periodic deliverables, alongside the profit anticipation and growth rate registered during the estimated timeframe.

A thorough inference pertaining to the performance of the Stem Cell Therapy market over the forecast period, along with the key factors driving the market growth is enclosed in the report. It also delivers information about the market dynamics and focusses on the challenges encountered by the business vertical while providing a brief about the growth opportunities prevailing in the market over the analysis timeline.

Key highlights of the Stem Cell Therapy market report:

The essence of the regional bifurcation of the business sphere presented in the report:

Top key players of industry are covered in Stem Cell Therapy Market Research Report:

Stem Cell Therapy Market Classification by Types:

Bytype1

Stem Cell Therapy Market Size by End-user Application:

Byapplication1

Additional insights about the competitive landscape of the Stem Cell Therapy market:

Factors defining the competitive landscape included in the report are:

The Stem Cell Therapy market report encompasses a comprehensive analysis of the key facets including market concentration ratio.

The objective of the Stem Cell Therapy Market Report:

Cataloging the competitive terrain of the Stem Cell Therapy market:

Unveiling the geographical penetration of the Stem Cell Therapy market:

The report of the Stem Cell Therapy market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Stem Cell Therapy Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Stem Cell Therapy Market report

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Our Trending Reports

Metabolomics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Stem Cell Therapy Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Influenza Diagnostics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Biomarkers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

3D Bioprinting Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read the original post:

Stem Cell Therapy Market Size By Types, By Application, By Region, And Forecast 20202027 - Owned

200 ALS Patients Finish Dosing in Phase 3 Trial of NurOwn Cell Therapy – ALS News Today

Posted on by

Patient dosing has finished in the pivotal Phase 3 trial assessing the safety and efficacy of repeat administrations of NurOwn, acell-based therapy forpeople with amyotrophic lateral sclerosis (ALS), BrainStorm Cell Therapeutics, the therapys developer, announced.

The Phase 3 trial (NCT03280056), which enrolled about 200 participants, is underway at six U.S. sites: the University of California, Irvine;Cedars-Sinai Medical Center;California Pacific Medical Center;Massachusetts General Hospital; the University of Massachusetts Medical School; and the Mayo Clinic.

Patients were randomly assigned to either three doses of NurOwn or a placebo, both administered every other month by injections directly into the spinal canal (intrathecal) over a period of four months.

The studys main goal is to assess the safety and efficacy of NurOwn, as measured by changes in the amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) score seen at 28 weeks (seven months) following the first treatment. ALSFRS-R assess such daily life abilities as swallowing, speaking, dressing and washing oneself, climbing stairs, and turning over in bed.

Secondary goals include treatment effects on the levels of several disease biomarkers, as found in samples of patients blood and cerebrospinal fluid (the liquid circulating in the brain and spinal cord).

BrainStorm expects top-line trial data to be available before the end of the year.

Completion of participant dosing in this clinical trial is an important milestone and brings us a step closer to potentially filing a biologics license application to make MSC-NTF cells [NurOwn] available to people with ALS, Chaim Lebovits, CEO of BrainStorm, said in the companyspress release.

NurOwn is a cell-based therapy that usesmesenchymal stem cells (MSCs) cells that are able to give rise to nearly all tissues found in the body, including bones, muscles, and connective tissue isolated from a patients own bone marrow.

After isolation, MSCs are grown in a lab dish and differentiated into cells that produce high levels of neurotrophic factors compounds that promote the growth and survival of nerve cells. The modified cells are then returned to patients through an injection into spinal canal.

Brainstorm is also investigating the potential of NurOwn treat other neurological disorders, including multiple sclerosis (MS), Huntingtons disease, Parkinsons disease, and autism spectrum disorder.

The open-label Phase 2 trial (NCT03799718) assessing three doses of NurOwn in people with progressive MSmay still be recruitingat two sites in the U.S. The cell-based therapy has not yet entered clinical testing for other disorders.

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells cells that made up the lining of blood vessels found in the umbilical cord of newborns.

Total Posts: 0

Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.

Go here to see the original:

200 ALS Patients Finish Dosing in Phase 3 Trial of NurOwn Cell Therapy - ALS News Today

Market Players Eye Opportunities in Emerging Economies to Gain Ground in the Stem Cell Therapies Market 2015 2025 Bulletin Line – Bulletin Line

Posted on by

Global Stem Cell Therapies market study presents an in-depth scenario which is segmented according to manufacturers, product type, applications, and regions. This segmentation will provide deep-dive analysis of the Stem Cell Therapies industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on past and present Stem Cell Therapies industry situations and growth aspects. All the key regions covered in Stem Cell Therapies report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Stem Cell Therapies market share and market outlook of each region from 2020-2027 are presented in this report. A deep study of Stem Cell Therapies market dynamics will help the market aspirants in identifying the business opportunities which will lead to accumulation of revenue. This segment can effectively determine the Stem Cell Therapies risk and key market driving forces.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-1087

Initially, the report presents the Stem Cell Therapies market overview covering product description, market analysis, market dynamics, opportunities and market share. Secondly, global report conducts a qualitative analysis to present the key manufacturers profile, Stem Cell Therapies market share, market size, sales volume, gross margin analysis.

The Stem Cell Therapies report is segmented to provide a clear and precise view of the global Stem Cell Therapies market statistics and market estimates. Stem Cell Therapies report Data represented in the form of graphs, charts, and figures will show the Stem Cell Therapies growth rate, volume, target consumer analysis. This report presents the crucial data to all Stem Cell Therapies industry aspirants which will facilitate useful business decisions.

Key Players

Some of the key players in this market are

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Regional analysis includes

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-1087

The Stem Cell Therapies report cover following data points:

Part 1: This part enlists the global Stem Cell Therapies market overview, covering the basic market introduction, market analysis by type, applications, and regions. The major Stem Cell Therapies producing regions include North America, Europe, Asia-Pacific, Middle-East, and Africa. Stem Cell Therapies industry states and outlook (2020-2027) is presented in this part. In addition, Stem Cell Therapies market dynamics stating the opportunities, market risk, and key driving forces are studied.

Part 2: This part covers Stem Cell Therapies manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Stem Cell Therapies product price, gross margin analysis, and Stem Cell Therapies market share of each player is profiled in this report.

Part 3 and Part 4: This part presents the Stem Cell Therapies competition based on sales, revenue, and market share of each manufacturer. Part 4 covers the Stem Cell Therapies market scenario based on regions. Region-wise Stem Cell Therapies sales and growth (2015-2019) is studied in this report.

Part 5 and Part 6: These two sections cover the North America and Europes Stem Cell Therapies industry by countries. Under this the Stem Cell Therapies revenue, market share of the countries like USA, Canada, and Mexico is provided. Under Europe Stem Cell Therapies report includes, the countries like Germany, UK, France, Russia, Italy, Russia and their sales and growth is covered.

Part 7, Part 8 and Part 9: These 3 sections covers Stem Cell Therapies sales revenue and growth for the regions like Asia-Pacific, South America, Middle East & Africa. Under these regions Stem Cell Therapies report covered, the countries like China, Japan, Korea, India, Brazil, Columbia, Argentina, Egypt, Saudi Arabia, Nigeria and South Africa. The sales and growth in these regions are presented in this Stem Cell Therapies industry report.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-1087

Part 10 and Part 11: This part depicts the Stem Cell Therapies market share, revenue, sales by product type and application. The Stem Cell Therapies sales growth seen during 2012-2020 is covered in this report.

Part 12 and Part 13: This part provides forecast information related to Stem Cell Therapies market (2020-2027) for each region. The sales channels including direct and indirect Stem Cell Therapies marketing, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These parts present Stem Cell Therapies market key research findings and conclusion, research methodology, and data sources are covered.

Thus, Global Stem Cell Therapies report is a complete blend covering all the vital market aspects.

The rest is here:

Market Players Eye Opportunities in Emerging Economies to Gain Ground in the Stem Cell Therapies Market 2015 2025 Bulletin Line - Bulletin Line

Cell Therapy Market Business Outlook, Top Manufacturers, Development Trends, Growth Projection and Forecast Research 2025 – Jewish Life News

Posted on by

The Cell Therapy Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Cell Therapy market report provides authentic and reliable estimates for the forecast period. The Best part of this report is, this analyses the current state where all are fighting with the COVID-19, The report also provides the market impact and new opportunities created due to the Covid19 catastrophe.

Leading Companies Reviewed in the Report are:

JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost and many more.

Get Exclusive Sample of Report on Cell Therapy market is available @ https://www.adroitmarketresearch.com/contacts/request-sample/611

The prime objective of this report is to help the user to gain a complete knowledge of the market in terms of its definition, segmentation, influential trends, market potential, and the challenges that the market is facing. The Cell Therapy Market report offers recorded market information from 2015 to 2019, reveals revenue estimations for 2020 and figures from 2020 till 2025

Cell Therapy Market highlights industry essentials, regional market, global economic industry growth, and market competitors along with their market share. Cell Therapy Market report is concluded through collecting the number of researches. Sever industry based analytical techniques were also analyzed for a better understanding of this market.

Quick Read Table of Contents of this Report @ https://www.adroitmarketresearch.com/industry-reports/cell-therapy-market

Global Cell Therapy market is segmented based by type, application and region.

Based on Type, the market has been segmented into:

By Use & Type Outlook, (Clinical-use,By Cell Therapy Type,,Non-stem Cell Therapies,Stem Cell Therapies,BM, Blood, & Umbilical Cord-derived Stem Cells,Adipose derived cells,Others), By Therapeutic Area, (Malignancies,Muscoskeletal Disorders,Autoimmune Disorders,Dermatology,Others,Research-use), By Therapy Type, (Allogenic Therapies,Autologous Therapies)

Cell Therapy market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

In addition, the number of business tactics aids the Cell Therapy market players to give competition to the other players in the market while recognizing the significant growth prospects. Likewise, the research report includes significant information regarding the market segmentation which is designed by primary and secondary research techniques. It also offers a complete data analysis about the current trends which have developed and are expected to become one of the strongest Cell Therapy market forces into coming future. In addition to this, the Cell Therapy report provides the extensive analysis of the market restraints that are responsible for hampering the Cell Therapy market growth along with the report also offers a comprehensive description of each and every aspects and its influence on the keyword market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/611

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

Read the original post:

Cell Therapy Market Business Outlook, Top Manufacturers, Development Trends, Growth Projection and Forecast Research 2025 - Jewish Life News

Hemostemix Files Its Audited Annual Financial Statements and Management Discussion and Analysis for the Period Ending December 31, 2019 – Yahoo…

Posted on by

Calgary, Alberta--(Newsfile Corp. - July 10, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") today filed on SEDAR its audited Financial Statements and Management Discussion and Analysis for the annual period and fourth quarter ending December 31, 2019 and for the comparable periods ending December 31, 2018.

ABOUT HEMOSTEMIX

Hemostemix is a publicly traded autologous stem cell therapy company. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and is commercializing its lead product ACP-01 for the treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and other conditions of ischemia. ACP-01 has been used to treat over 300 patients, and it is the subject of a randomized, placebo-controlled, double blind trial of its safety and efficacy in patients with advanced critical limb ischemia who have exhausted all other options to save their limb from amputation.

On October 21, 2019, the Company announced the results from its Phase II CLI trial abstract entitled "Autologous Stem Cell Treatment for CLI Patients with No Revascularization Options: An Update of the Hemostemix ACP-01 Trial With 4.5 Year Followup" which noted healing of ulcers and resolution of ischemic rest pain occurred in 83% of patients, with outcomes maintained for up to 4.5 years.

The Company owns 91 patents across five patent families titled: Regulating Stem Cells, In Vitro Techniques for use with Stem Cells, Production from Blood of Cells of Neural Lineage, and Automated Cell Therapy. For more information, please visit http://www.hemostemix.com.

Contact: Thomas Smeenk, President, CEO & Co-FounderTSmeenk@Hemostemix.com 905-580-4170

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined under the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: the commercialization of ACP-01. There can be no assurances that such forward-looking information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information. This forward-looking information reflects Hemostemix's current beliefs and is based on information currently available to Hemostemix which the Company believes are reasonable. These assumptions include, but are not limited to: the results of ACP-01 research, trials and studies being equivalent to or better than previous research, trials or studies as well as management's expectations of anticipated results; Hemostemix's general and administrative costs remaining constant; the receipt of all required regulatory approvals for research, trials or studies as well as any required or desired financings of Hemostemix, including TSX Venture Exchange acceptance and any third party consents; the level of activity, market acceptance and market trends in the healthcare sector; the economy generally; consumer interest in Hemostemix's services and products; competition and Hemostemix's competitive advantages; and obtaining satisfactory financing to fund Hemostemix's operations including any research, trials or studies. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Hemostemix to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the ability of Hemostemix to complete its current CLI clinical trial, complete a satisfactory futility analysis and the results of such and future clinical trials; litigation and potential litigation that Hemostemix may face; general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive board or regulatory approvals; the actual results of future operations including the actual results of future research, trials or studies; competition; changes in legislation affecting Hemostemix; the timing and availability of external financing on acceptable terms; long-term capital requirements and future developments in the Company's markets and the markets in which it expects to compete; lack of qualified, skilled labour or loss of key individuals; and risks related to the COVID-19 pandemic including various recommendations, orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, service disruptions, quarantines, self-isolations, shelters-in-place and social distancing, disruptions to markets, economic activity financing, supply chains and sales channels, and a deterioration of general economic conditions including a possible national or global recession; the potential impact that the COVID-19 pandemic may have on Hemostemix may include a decreased demand for the services that Hemostemix offers; and a deterioration of financial markets that could limit Hemostemix's ability to obtain external financing. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in Hemostemix's disclosure documents on the SEDAR website at http://www.sedar.com. Although Hemostemix has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Hemostemix as of the date of this news release and, accordingly, is subject to change after such date. However, Hemostemix expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Story continues

The rest is here:

Hemostemix Files Its Audited Annual Financial Statements and Management Discussion and Analysis for the Period Ending December 31, 2019 - Yahoo...

Stem Cell Alopecia Treatment Market Size By Types, By Application, By Region, And Forecast 20202027 – Owned

Posted on by

New Jersey, United States,- The Stem Cell Alopecia Treatment Market report upholds the future market predictions related to Stem Cell Alopecia Treatment market size, revenue, production, Consumption, gross margin, and other substantial factors. It also examines the role of the prominent Stem Cell Alopecia Treatment market players involved in the industry including their corporate overview. While emphasizing the key driving factors for the Stem Cell Alopecia Treatment market, the report also offers a full study of the future trends and developments of the market.

The recently documented report on the Stem Cell Alopecia Treatment market is a detailed analysis of this business landscape and contains important details regarding the present market trends, current revenue, market size, industry share, periodic deliverables, alongside the profit anticipation and growth rate registered during the estimated timeframe.

A thorough inference pertaining to the performance of the Stem Cell Alopecia Treatment market over the forecast period, along with the key factors driving the market growth is enclosed in the report. It also delivers information about the market dynamics and focusses on the challenges encountered by the business vertical while providing a brief about the growth opportunities prevailing in the market over the analysis timeline.

Key highlights of the Stem Cell Alopecia Treatment market report:

The essence of the regional bifurcation of the business sphere presented in the report:

Top key players of industry are covered in Stem Cell Alopecia Treatment Market Research Report:

Stem Cell Alopecia Treatment Market Classification by Types:

Bytype1

Stem Cell Alopecia Treatment Market Size by End-user Application:

Byapplication1

Additional insights about the competitive landscape of the Stem Cell Alopecia Treatment market:

Factors defining the competitive landscape included in the report are:

The Stem Cell Alopecia Treatment market report encompasses a comprehensive analysis of the key facets including market concentration ratio.

The objective of the Stem Cell Alopecia Treatment Market Report:

Cataloging the competitive terrain of the Stem Cell Alopecia Treatment market:

Unveiling the geographical penetration of the Stem Cell Alopecia Treatment market:

The report of the Stem Cell Alopecia Treatment market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Stem Cell Alopecia Treatment Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Stem Cell Alopecia Treatment Market report

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Our Trending Reports

Neurotrophic Keratitis Treatment Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Stem Cell Alopecia Treatment Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Copper Busbar and Profiles Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Europe Pre-Insulated Plastic Pipes Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Wood Coatings Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

View original post here:

Stem Cell Alopecia Treatment Market Size By Types, By Application, By Region, And Forecast 20202027 - Owned

Stem Cell Banking Storage Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -…

Posted on by

New Jersey, United States,- Latest update on Stem Cell Banking Storage Market Analysis report published with extensive market research, Stem Cell Banking Storage Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Stem Cell Banking Storage industry. With the classified Stem Cell Banking Storage market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Stem Cell Banking Storage market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Stem Cell Banking Storage market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Stem Cell Banking Storage Market growth opportunities in the industry.

Stem Cell Banking Storage Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Stem Cell Banking Storage market size, volume and value, as well as price data.

Stem Cell Banking Storage Market competition by top Manufacturers:

Stem Cell Banking Storage Market Classification by Types:

Stem Cell Banking Storage Market Size by End-user Application:

Listing a few pointers from the report:

The objective of the Stem Cell Banking Storage Market Report:

Cataloging the competitive terrain of the Stem Cell Banking Storage market:

Unveiling the geographical penetration of the Stem Cell Banking Storage market:

The report of the Stem Cell Banking Storage market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Stem Cell Banking Storage Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick lookup into Stem Cell Banking Storage Market report

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read more:

Stem Cell Banking Storage Market Size By Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies And Forecast Up To 2026 -...

Check Out This Beatboxer Cover the Cyberpunk 2077 Theme – Enter21st

Posted on by

If you recognize in regards to the upcoming Keanu Reaves starred, probably the most hyped video video games of 2020, Cyberpunk 2077, then you definately is likely to be accustomed to the superior theme music of the sport. However, what you wont be accustomed to is that this insane cowl of the techno theme music of the sport by this loopy beatboxer.

Going by the identify Improver, the man gained the Russian Beatbox Championship final 12 months, as said in his Instagram bio. Well, lets simply say he deserved it and theres a motive he gained the competitors. It is as a result of hes that good in his space of experience. Just check out the video beneath and inform me hes not insane (I dare you!).

Now, as you possibly can see, he has a madly proficient pair of lips, throat, and voice modulation functionality. And as he specializes within the techno style, masking this piece from the upcoming sci-fi RPG sport was a breeze for Improver.

After successful the Russian Beatbox Championship, Improver made numerous wonderful movies for his YouTube Channel. However, going by all his profiles, the man didnt, in any platform, share his identify. All we all know is that hes from Ulyanovsk, Russia, and is a professional beatboxer.

Now, coming to Cyberpunk 2077. From earlier stories, we all know how a lot hype is across the upcoming online game. But the dystopian RPG is being delayed for fairly a very long time now. After an preliminary delay in launch, the sport was set to come back in September. However, lately the date was once more moved additional to November 19.

More here:

Check Out This Beatboxer Cover the Cyberpunk 2077 Theme - Enter21st

Top 10 Cyberpunk Films From The ’90s, Ranked (According To IMDb) – Screen Rant

Posted on by

Cyberpunk films are often confused with generic science fiction films. While the comparison isn't baseless, doing so ignores what makes cyberpunk unique. The main difference is that cyberpunk refers tostories set indystopias dominated by technology, machines, and/or Artificial Intelligence (AI), whereas science fiction is more broad in its subject matter.The subgenre isstill a big deal today, but cyberpunk was arguably at the top of its game in the '90s.

RELATED:10 Cyberpunk Sci-Fi Books Too Twisted To Be Made Into Films

Back then, the subgenre was more prevalent due to the fact that new technology was rapidly emerging and changing life on an almost daily basis. There are a number of cyberpunk films that gained more popularity and others that are worth watching if never heard of. Here are the 10 best cyberpunk of the '90s, ranked by their IMDb scores.

When googling popular cyberpunk films from the era, Existenz always shows up and for good reason. Directed by David Cronenberg, the film is rightfully filed underscience fiction horror but it still holds some notable cyberpunk elements as well.

In a distant future, gaming has upgraded from electronic consoles to virtual pods. The pods are connected to the gamer's spine. Allegra Geller (Jennifer Jason Leigh) is a game designer who finds herself the target of assassins. She was meant to demonstrate her latest virtual reality game and finds herself having to enter the game in order to make sure its structure isn't compromised.

For any Sylvester Stallone fan, Demolition Man is one of his guiltiest of guilty pleasures from the '90s. The film originally starts in the year 1996 where LAPD Sergeant John Spartan (Stallone) is after his number one nemesis. After hostages are killed, Spartan and Phoenix(Wesley Snipes) are imprisoned by being cryogenically frozen.

Fastforward to 2032, Phoenixescapes his parole hearing and Spartan is the only one who can stop him. He must adjust to a new worlddominated by technology anda new social order where political correctness has been taken to a satirical extreme.

Bicentennial Man is on the cut off before entering the 2000's. Despite this, it still deserves mention among its '90s peers for its unique outlook on AI technology. While the film was a box office failure, it still gets mentioned in science fiction crircles.

The film starred Robin Williams in the main role of Andrew. In 2005, "Andrew" is a robotic AI introduced to the Martin family to perform household duties. As time passes he starts to exhibit human qualities that were not part of his original programming. The film also transports 20 years into the future of Andrew's evolution.

The Thirteenth Floor will take any viewer on a cyberpunk trip into virtual reality. The film can be titled ascyberpunk due to thefact that it plays on the concept of what's real and what's virtual. In 1999, the creator and owner of a new virtual reality system is murdered. The VR system creates Los Angeles in 1937 with simulated humans.

RELATED:10 Cyberpunk Masterpieces Youve Probably Never Seen

Douglas Hall (Craig Bierko)becomes a suspect and heir to the company. Hall enters the virtual reality to find a message left behind by his predecessor. His world turns upside down and must distinguishreality from the simulation.

While Strange Days doesn't involve jumping between present and future, it does have advanced technology. The film follows former LAPD officer turned black marketeer Lenny Nero (Ralph Fiennes), who specializes in the selling of recorded memories and experiences through the virtual reality device known as the SQUID.

Los Angeles has turned into a war zone as social unrest leads to riots and amidst all this chaos, a prostitute is murdered for the recording pleasure of a SQUID user. Lenny tracks down the SQUID recordings and finds himself in the middle of a vast conspiracy and cover-up.

The originalTotal Recall is a film that was a lukewarm success in its time butenjoyed a cult following after the '90s. It's also titledunder science fiction but its plot elements also sway towards cyberpunk. The film takes place in 2084 where technology reigns supremer and interspace travel is somewhat normal. Douglas Quaid (Arnold Schwarzenegger) has recurring dreams of Mars and a mysterious woman.

RELATED:5 Best & 5 Worst Cyberpunk Movies, According To Rotten Tomatoes

He goes to Rekall a facility that specializes in implanting false memories to the clients' desires. Quaid's procedure goes wrong (or does it?) and his supposed real life isn't actually his own.

There is a common debate on whether or not The Fifth Element is more sci-fiwith cyberpunk elements or if it can be called cyberpunk at all due to its approach to certain characters, locations and themes that aremore of a space opera than cyberpunk.

However, the film does take place in a distant future in the year 2263, and some fans recall the beginning scenes of a futuristic New York City to be considered cyberpunk mainly becausethe city is a mass of high rises that live above smog. That, and thereare flying cars and restaurants fly up to apartment windows. There are also other elements such as robots taking over menial jobs like bartending. A bigger majority of the film is science fiction with elements of cyberpunk.

12 Monkeys is a science fiction film, but many regard Terry Gilliam's film as a neo-noir, dystopian and cyberpunk. The film has many elements from these aforementioned niches that can be considered part ofthe genre for its visually distinct use of time travel.

In 2035, what is left of the human race lives in a subterranean compound underneath Philadelphia. James Cole (Bruce Willis) is a prisoner who is trainedto travel back to 1996 to find the origins of the deadly virus. 12 Monkeyswas a major success and while critics considered the story to be a little jumbled, the acting and plot twist made for a great film.

The originalGhost in the Shell isn't just one of the most highly regarded examples of cyberpunk, but it's also considered to be one of the best animated features ever made. Japanese in origin, thislandmarkanime film is based on the manga of the same name by Masamune Shirow. The movie spawned a vast franchise of series and movies, though the original remains the best.

Set in 2029 Japan, a technological future allows for body parts to be replaced by cybernetic ones. Advancements in technology also created a cyber brain or "Ghost." Motoko Kusanagi(Atsuko Tanaka)is a cyborg public-security officer who tracks down a hacker. The film interweaves philosophical themes and the implications of an advanced technological world.

It's no surprisethat the most acclaimed science fiction and cyberpunk film of the '90s is The Matrix. The Matrix and its franchise are one of the top films regarding AI and simulated reality. It has amassed an immense cult following since its premiere and it continues to make people rethink reality and existence itself.

The film stars Keanu Reeves as Thomas Anderson or "Neo." Neo is a hacker who sees bizarre occurrences in the world and the appearance of the Matrix. He soon discovers the real world to only be a simulation. In reality, the world was run over by machines who entrapped humans for their bioelectric power to survive. A group of free humans hopes to fulfill the prophecy and find "the one" who will end the rule of the machines.

NEXT:5 Sci-fi Films From The 2000s That Are Way Underrated (& 5 That Are Overrated)

Next Harry Potter: 5 Patronus Animals Aries Would Likely Have (5 They Never Would)

Gabriela is an Entertainment writer with experience in all things, Tv, Film and pop culture. She's more than happy to stay in and binge-watch new TV shows and movies on Netflix.

Go here to see the original:

Top 10 Cyberpunk Films From The '90s, Ranked (According To IMDb) - Screen Rant

Sealand – Simple English Wikipedia, the free encyclopedia

Posted on by

Sealand is a self-claimed country in the North Sea approximately 12 km from the coast of Suffolk. Sealand is a structure called Roughs Tower it was built in the sea by the British Royal Navy, and later became Sealand. It is very small. There is only room for 300 people on it. Even though a man named Michael Bates says Sealand is a country, no other country has supported this claim.

The owners claim that Sealand is an independent sovereign state because in 1968 an English court decided that Roughs Tower was in international waters and outside the jurisdiction of the British courts.[8]

There are no other states that have diplomatic recognition for Sealand. In the declaratory theory of statehood, an entity becomes a state as soon as it meets the minimal criteria for statehood. Therefore, recognition by other states is purely "declaratory".[9]In 1987, the UK extended its territorial waters from three to twelve miles. Sealand now sits inside waters that Britain claims as its territory.[10]

Irrespective of its legal status, Sealand is managed by the Bates family as if it were a recognised sovereign entity, and they are its hereditary royal rulers. Roy Bates styles himself "Prince Roy" and his wife "Princess Joan". Their son is known as "His Royal Highness Prince Michael" and has been referred to as the "Prince Regent" by the Bates family since 1999.[11] In this role, he apparently serves as Sealand's acting "Head of State" and also its "Head of Government".[12] At a micronations conference hosted by the University of Sunderland in 2004, Sealand was represented by Michael Bates' son James, who was referred to as "Prince Royal James."[13] The facility is now occupied by one or more caretakers representing Michael Bates, who himself resides in Essex, England.[11] Sealand's constitution was instituted in 1974. It consists of a preamble and seven articles. The preamble asserts Sealand's independence, while the articles variously deal with Sealand's status as a constitutional monarchy, the empowerment of government bureaus, the role of an appointed, advisory senate, the functions of an appointed, advisory legal tribunal, a proscription against the bearing of arms except by members of a designated "Sealand Guard", the exclusive right of the sovereign to formulate foreign policy and alter the constitution, and the hereditary patrilinear succession of the monarchy.[14] Sealand's legal system is claimed to follow British common law, and statutes take the form of decrees enacted by the sovereign.[15] Sealand has issued passports and has operated as a flag of convenience state, and it also holds the Guinness World Record for "the smallest area to lay claim to nation status".[16] Sealand's motto is E Mare Libertas (English: From the Sea, Freedom).[a] It appears on Sealandic items, such as stamps, passports, and coins, and is the title of the Sealandic anthem. The anthem was composed by Londoner Basil Simonenko;[17] it does not have lyrics.

At the beginning of 2007, the Bates put an ad in the newspaper. They would like to sell Sealand for 65 million pounds.[18][19]National motto: E mare libertas(Latin: From the sea, freedom)

Read more:

Sealand - Simple English Wikipedia, the free encyclopedia

After Six Months and Little Progress Controlling the Pandemic, Return to Normal Remains Out of Sight – Centralia Chronicle

Posted on by

It's been nearly half a year since the first case of COVID-19 was identified in the United States, in the Puget Sound area, on Jan. 21.

While the state eventually shut down in late March in an effort to slow the disease's spread, Washington began the gradual process of reopening after little more than a month.

But as counties began moving through the stages of the state's phased reopening plan, the coronavirus was just beginning its wider spread outside the Seattle area and into other parts of the state, including to Yakima, the Tri-Cities and, eventually, Spokane.

Since April, after a particularly bad first wave in Western Washington, Central and Eastern Washington have been hit with their own first waves of the virus, leading to newly reopened restaurants shutting down all over again, to outbreaks in prison units and food processing plants, and to community spread, even in rural counties.

Case rates statewide are higher now, with half the counties partially reopened, than they were in April, and state public health officials have paused any further reopening for now.

In Spokane, hospitalizations have doubled in a month, and intensive care capacity remains a concern due to questions about staffing levels.

In Yakima, where Gov. Jay Inslee's masking orders first went into effect , patients were sent to hospitals outside the area when staff needs hit capacity.

Franklin County has the highest percent-positive rate in the state, with 32% of individuals tested in the last two weeks returning positive results.

Six months into the pandemic, it feels like not a lot has changed.

Test results are backed up again, with people having to wait a week to 10 days in isolation to see if they are positive or negative. Community spread, when the virus is contracted without known connections to other cases, is back on the rise, as it was in March and April.

The rising number of cases has put increased challenges and pressure on contact tracing efforts, which began with reopening and are now incredibly strained and overwhelmed.

Despite the state training hundreds of workers and National Guard members to do contact tracing, counties like Spokane have opted to hire outside companies to conduct contact tracing. With more than 460 cases confirmed this week alone, the work has eclipsed what local epidemiologists can handle.

The ripple effect

Washington was on lockdown from late March to early May, giving public health officials and state leaders an opportunity to prepare outbreaks underway and on the way, predominantly in long-term care facilities across the state and more broadly in the Puget Sound area.

By May, residents were antsy, and reopening lurched forward, with Ins-lee's phased plan taking effect.

Despite state leaders' efforts to ensure counties were ready to move ahead, it's apparent now they miscalculated in some cases. Some counties hadn't had their first wave yet.

According to Eric Lofgren, an epidemiologist at Washington State University, some took the absence of cases in some areas as evidence the virus had been safely contained. In reality, he said, the first wave hadn't fully reached parts of Eastern Washington, including Spokane and the Tri-Cities.

"If you don't have cases, that means either your epidemic hasn't started yet or you've successfully controlled it," Lofgren said. "So I think everyone said we successfully controlled it, and what we discovered was that in several states we discovered that your epidemic was a little slower in coming."

The same story played out across the country in states that reopened this summer after seeing relatively low case counts -- but are now seeing hospitalizations and case counts surge.

Washington is now seeing higher daily case counts in July than April.

Testing capacity is back to waits of 10 days to two weeks for results , largely due to rising demand and growing backlogs at national laboratories, where the majority of the country's testing capacity lies.

"We are truly back to where we were in March," Spokane County Health Officer Bob Lutz said Friday, noting the challenges felt in Spokane are felt statewide and nationally .

Long wait times make it challenging for public health officials asking people to isolate at home until they get test results.

"Delays are harmful because they don't allow us to quickly contain a case," Secretary of Health John Wiesman told reporters Thursday. "We know people are most infectious early on ... and that's why we say to anybody getting a test that if you have any reason to get a test, we want you to stay home until you get your results."

With more testing, came more cases, but that doesn't paint the full picture of the disease burden.

The statewide percent-positive rate has also steadily increased this summer, as has the rate of people testing positive in counties per 100,000 people. Only 16 counties statewide are meeting case rate goals set by the governor's Safe Start plan.

Could more have been done during the state's lockdown to prevent the COVID-19 resurgence? Lofgren thinks so.

"I think at both a national and local level, what happened is we did sort of waste the opportunities we had to get things in place for people to start taking this seriously, to put testing strategies in place," he said.

The state's positive rate is back up to nearly 6%, and modelers are now confident the epidemic was growing in both Eastern and Western Washington in mid- to late June.

"While the resurgence in cases was originally limited to a few hot spots, upward trends are now prominent in most counties," the most recent state modeling report says.

Summer is nearly half over, and schools are set to open in less than two months. With so much of the response feeling like dj... vu, health officials lament the lost time.

"We had breathing room, and we've largely used it on politicizing the epidemic," Lofgren said.

Finding a treatment

In half a year, treatment options for COVID-19 have improved, but doctors and researchers are still far from a treatment that works even half the time on patients who are hospitalized with the virus.

Two standout treatments, remdesivir and dexamethasone, appear to have some positive results, although the studies are ongoing and results are still preliminary in both clinical trials.

A study from a large drug trial led by Oxford University researchers found that dexamethasone, a common steroid, was helpful in treating patients with COVID-19 who were on oxygen or ventilated. While their study has not yet been peer-reviewed or published, their early results look somewhat promising. The steroid kept one person in a group of 20 with severe symptoms from dying .

These results are impressive in the drug trial world, but they have a long way to go before proving entirely useful.

Both MultiCare and Providence hospitals have enrolled in the clinical trials for remdesivir guided by the National Institutes of Health, and Dr. Henry Arguinchona, an infectious disease practitioner at Sacred Heart Medical Center, said initial trials of the drug also look promising.

Patients receiving remdesivir in the trial are faring better than those who get the placebo. The trial will soon move into its third phase; second phase results are forthcoming.

Early in the pandemic, ventilators were an in-demand lifesaving tool . While they are still being used for some patients, physicians are not immediately putting patients on them anymore. The National Institutes of Health now recommends a less invasive intervention -- a high-flow nasal cannula -- over a ventilator in some instances.

Some patients are doing well and able to get more oxygen to their lungs when they are simply flipped onto their stomachs, Arguinchona said, another technique doctors, nurses and intensivists are using.

"I feel that we know better now how to take care of these patients, but I am hopeful that one or two or three or four months now, we know even more," Arguinchona said.

Recovering from COVID-19 is far from a linear process, and some people have experienced ongoing symptoms or side effects of their body's fight with the virus for months. As The Atlantic's Ed Yong notes, some people with COVID-19 and ongoing illness call themselves "long-haulers." Yong writes that they are "navigating a landscape of uncertainty and fear with a map whose landmarks don't reflect their surroundings."

Arguinchona said the phenomenon of patients not getting better is being seen more and more in COVID patients, but he noted that lingering health conditions are not necessarily indicative of persisting virus in the person.

"There are many infections a person can get, and afterwards they can get a postinfectious syndrome," Arguinchona said. "They can be left with lingering symptoms. With regards to post-COVID-19 symptoms, it's not known what the causes or etymology of those is."

The Centers for Disease Control and Prevention considers a patient who is not admitted to the hospital with the virus as having a mild case, but Lofgren notes that "mild" doesn't really give weight to potential symptoms and conditions patients experience.

"There are a lot of people who had supposedly mild cases of COVID who are still struggling with lung function and struggling with cardiovascular issues," Lofgren said.

Who is impacted by COVID-19

The virus has exposed the inequities that already run rampant throughout the American health care system, including here in Washington.

When adjusted for population size, Hispanics and Pacific Islanders have nine times the number of COVID-19 cases than white people in Washington. The disproportionate rates of the virus trickle into hospitalizations and deaths from the virus , and nonwhite communities are hit hard by the virus statewide.

In Spokane County, the Marshallese community has experienced devastating effects of the virus.

"The pandemic has exacerbated the underlying and persistent inequities among historically marginalized communities and those disproportionately impacted due to structural racism and other forms of systemic oppression," a July 8 report from the Department of Health says.

The department allotted a half-million dollars to get community organizations funding to bolster virus prevention and response efforts in a large swath of communities statewide. DOH awarded dozens of community organizations contracts that ranged from $5,000 to $20,000 to fund communication and emergency outreach services for communities that are disproportionately impacted by the virus.

Some pregnant women are also not faring well if they contract COVID-19. A CDC report found that pregnant women with COVID-19 are more likely to be hospitalized and are at increased risk for ICU admission than nonpregnant women. Nationwide, 11,312 pregnant women have contracted the virus, and 31 of them have died.

Arguinchona said some pregnant women have become very ill with COVID.

Young people, who were not as impacted at the beginning of the pandemic, are now driving case counts locally, statewide and nationally.

Twenty- and 30-somethings make up 38% of confirmed COVID-19 cases statewide and 45% of cases in Spokane County.

In recent weeks, health officials have pleaded with young people to stop gathering in large groups and to wear masks when around one another. Most young people might experience mild symptoms with the virus, but the fear is that they will bring the virus to their older parents or grandparents, or spread the virus when they are at work.

"We have a lot of work to do with younger folks here in Washington limiting their social interactions and make sure they're wearing masks," State Health Officer Kathy Lofy told reporters on July 8.

Back to school?

With the start of the school year less than two months away, community members and public health officials remain skeptical that kids will be back in their classrooms.

Dr. David Line, the public health program director at Eastern Washington University, says the county will "pay for our actions," including July 4 gatherings with case counts and hospitalizations.

At the end of the first wave, if enough of the community has started wearing masks and adhering to small gathering requirements, it should be doing well, he said.

"If we aren't doing well at the end of (the next) seven weeks, if we don't have a low caseload, we are in really big trouble because that's when school starts," Line said. "... If we miss that window that occurs right now through the rest of the summer, we will not be able to contain that wildfire at least through all next school year."

Wearing masks and face coverings could determine what school districts do when school begins.

Lofgren has studied how schools can stay open and avoid transmission of infectious disease.

"It's possible ... we can have school, but it's not as fun as it used to be," he said. "It's possible we can't get a 5-year-old to wear a mask, but we can get an 8-year-old to wear a mask."

Measures such as not allowing group activities such as band and choir, having teachers instead of students move from classroom to classroom, and having students eat in the classroom, could help minimize widespread interaction of students in schools.

Schools might use hybrid models of partial reopening , depending on the district and the county's phase of reopening . The Office of Superintendent of Public Instruction wants schools to reopen in-person but officials acknowledge districts in Phase 1 or modified Phase 1 counties might have to implement additional safety measures.

DOH guidance for schools requires universal masking but leaves additional measures at the discretion of school districts.

As for colleges, research indicates congregate living settings like dorms are perfect breeding grounds for virus transmission.

A group of college students from the University of Texas who went to Cabo San Lucas for spring break in March ended up in a perfect COVID environment. Three symptomatic students were tested when they returned, and the contact tracing investigation revealed 64 total people had contracted the virus.

Shared housing both on-campus and during their spring break trip led researchers to believe that patterns of living and interacting in close settings could lead to "propagated spread, similar to the continued person-to-person transmission observed in long-term care facilities."

'The better part of a year'

As Washington and other states experience a surge in cases this month, health officials insist widespread mask use is key to bringing down transmission rates in the near future.

For EWU's Line, it comes down to community buy-in on masking and cooperation with contact tracing efforts.

"We could do nothing and let the whole thing burn up. We could do this fake open-close thing and suffer the whole way through. Or we can do some pretty simple things and get full support by everybody and not have to suffer and be fine in seven to eight weeks," he said.

The Department of Health and the CDC recommended the use of face coverings in early April, but mandates took longer. Leaders hoped residents would take the advice and wear face coverings, in place of hunkering down at home. That didn't work.

In mid-May, some local jurisdictions, including King and Spokane counties, mandated masks, though the mandates weren't always enforced.

Statewide, however, masks were not required for all residents until late June. That requirement is likely to remain in place for a long time.

"Wear a mask, social distance, try to take responsibility for your own part of this outbreak, and that means things aren't going to be fun for a while and that's hard, but those sacrifices mean maybe kids can go to school, maybe those stressed households are less stressed," Lofgren said.

The notion that we will be "done" with COVID-19 soon is not realistic, Lofgren said.

"We need to start engaging with the idea that this isn't a couple months," he said. "It's the better part of the year."

Researchers and health care providers are working overtime around the country and the world to find out just how effective and long-lasting antibodies are, and how effective a vaccine could be as a result.

"We're not promised a treatment or a vaccine," Lofgren said.

See the original post here:

After Six Months and Little Progress Controlling the Pandemic, Return to Normal Remains Out of Sight - Centralia Chronicle

Weddings pose threat to Turkeys coronavirus progress | Daily Sabah – Daily Sabah

Posted on by

After months of waiting for permission from authorities for weddings to resume, couples were finally allowed to tie the knot on July 1, but officials now mull whether the decision was wrong, as health experts warn weddings pose a significant risk to Turkeys coronavirus fight.

On a regular year, spring marks the beginning of the wedding season in Turkey, but it is the summer when the ceremonies pick up the pace. Wedding motorcades on roads, the grooms friends doing their best to perform local dances outside the brides house and the extravagant ceremonies itself become an increasing sight with the summer.

But the outbreak changed it all. At least thats what the authorities had hoped for.

Shortly after the Health Ministry announced the countrys first COVID-19 case on March 10, weddings were among the many other things that were restricted. While the outbreak negatively impacted almost everyones lives, weddings perhaps suffered the most as most couples arrange their weddings nearly a year in advance, with most of the things already decided upon and down payments done.

For the first two months of the outbreak, couples were certain they would have to postpone their weddings to next year as the outbreak only worsened in Turkey. But in late April, Turkey managed to not only flatten the curve but actually significantly reduce the rate of daily new infections.

With the improving outlook, the government removed most of the restrictions on June 1, including the lifting of intercity travel restrictions and allowing restaurants, cafes and gyms to reopen.

But weddings still posed a risk. It took another month for authorities to allow weddings to resume under severe restrictions which would turn the ceremonies a far cry from traditional festivities. The move was criticized even back then by health experts as too early and too risky. And they might have been right.

What rules?

Following the decision, the Interior Ministry outlined the rules that people would have to follow at weddings.

Wedding parties will be short and held outdoors as much as possible while guests are required to wear masks and sit at least 1.5 meters (4.9 feet) apart from each other.

Only the newlywed couple is permitted to dance. Handshakes and hugs are banned and gifts usually gold coins and jewelry will be required to be placed in a box, instead of attaching it on the dress and suit of the newlywed couple.

Mass photoshoots of guests with the couple are also banned, and guests can only take a photo with the couple by adhering to social distancing.

Wedding halls are also required to hold weddings in one day with at least one hour between two weddings, to enable proper ventilation of the building. To the chagrin of children who prefer playing instead of joining adults dancing, playgrounds in wedding halls will be closed.

In their attempt to allow weddings to resume, the authorities issued rules even for the finer details, but soon after the ceremonies resumed, scenes emerged showing that they mattered little, as many people attending the weddings ignored them in favor of festivities.

Since the weddings resumed, photos and videos circulated on news outlets and social media that showed attendees standing shoulder to shoulder and performing the halay dance, a staple of Turkish weddings.

A similar disregard for rules was witnessed with the couples posing with guests for photos, or guests getting in crowded queues to gift their gold coins in person.

Health Minister Fahrettin Koca and other experts repeatedly warned that such scenes were perfect ways to contract the virus, but their warnings were left unheeded. With warnings ignored, many governorates decided to introduce further restrictions in their respective provinces.

The northern province of Karabk decided to restrict weddings to a maximum of three-hour ceremonies, while eastern Hakkari announced the duration as four hours. Ktahya province, meanwhile, banned all ceremonies and festivities outside of wedding halls.

Meanwhile, the Health Ministry introduced observers for weddings, a designated person who will make sure the rules are followed, from social distancing to wearing masks.

While members of the countrys Coronavirus Science Board claimed the majority of the weddings were carried out in line with rules and that violations occurred at around 10% of the weddings, one member of the board still warned senior citizens to avoid weddings.

The elderly should avoid going to weddings. If they must go, they should wear their mask and leave as soon as possible. What we really want is for our seniors and other at-risk groups to skip weddings altogether, professor Hasan Tezer said.

See the rest here:

Weddings pose threat to Turkeys coronavirus progress | Daily Sabah - Daily Sabah

Bunny cuddles, fluffy feathers, and a rooster riding piggyback – Progress Index

Posted on by

Dinwiddie Animal Swap and Farmers Market kicks off the season

DINWIDDIE - Locals hoping to add some furry and feathered pets to their family showed up at the Dinwiddie Animal Swap and Farmers Market held at the Tractor Supply Company on Saturday.

"Due to the coronavirus pandemic, this is the first one of our third season," shared host and founder Jessica Lowe of Dinwiddie. "We have a good turnout here today selling, swapping, or trading chickens, ducks, pigs, jewelry, farm fresh eggs, baked goods, turkeys, essential oils, produce, herbal teas, quails, and much more."

Over 15 vendors set up their wares and livestock for sale in the grassy area along Boydton Plank Road. Temperatures reached the 90s, and most everyone used canopies to protect themselves and their critters from the sun.

According to Lowe, their mission is to provide access to locally grown farm animals and produced products to create a sense of community, and their goal is to increase access to locally produced nourishing and safe foods for all to enjoy.

"My mom [Becky Woods] and I have participated in swaps together since I was 10...so I guess about 14 or 15 years now," said Tiffany Crowder of Dinwiddie. "We did it through the Dinwiddie 4-H."

The monthly event is designed to encourage, support and promote entrepreneurs' efforts of local growers and artisans seeking to sell products, produce and farm animals directly to consumers and the community.

"We aim to create an opportunity for people to meet, greet, eat, learn, and to share stories, recipes and knowledge in a place dedicated to the cultivation of local products, talents, and crafts," said Lowe.

All of The Progress-Indexs coverage of coronavirus is being provided for free to our readers. Please consider supporting local journalism by subscribing to The Progress-Index at progress-index.com/subscribe.

"We like to talk shop about farming and the artisan community," said vendor Carmen Kraus of Dinwiddie. "I sell soaps, salves, gemstones and jewelry."

"We strive to create an atmosphere that serves our community not only the market but contributes to our prosperous rural areas while promoting a great sense of community," said Lowe. "Our season goes into November, and I hope to see everyone."

Are new vendors welcome?

"We welcome new vendors," said Lowe. "Were still relatively small at this time, so there is no vendor fee."

The swap and market takes place on the second Saturday of the month from 10:00 a.m. - 2:00 p.m. For more information, visit Dinwiddie Animal Swap and Farmers Market on Facebook or email DinwiddieSwapsTSC@gmail.com.

Kristi K. Higgins can be reached at khiggins@progress-index.com. On Twitter: @KristiHigginsPI

Continued here:

Bunny cuddles, fluffy feathers, and a rooster riding piggyback - Progress Index

McLaren: Were making progress in the right direction – Grand Prix 247

Posted on by

McLaren report from the Styrian Grand Prix, Round 2 of the 2020 Formula 1 World Championship at Red Bull Ring in which their drivers Lando Norris finished fifth and Carlos Sainz crossed the line in ninth.

Carlos Sainz: A very disappointing day for me. We missed out on big points after a problem at the pit-stop. The first part of the race we were running P5 with a solid pace and managing the gap to the cars behind.

Unfortunately, we had a bad pit-stop, which meant we came out of the pits in the middle of traffic. I had to push too hard too early to try to recover the gap, and that drained my battery and ultimately compromised my tyres for the second part of the race.

One of those days when nothing goes your way. Time to turn the page and come back stronger, but we missed out on a good P5 today. We win and we lose as a team, so well try to fight back in Hungary next week.

Lando Norris: A very good race from us today. First of all, the team did an awesome job with the strategy and I did a good job with managing the Soft tyres in the first stint.

We got to lap 39 before we boxed and that was one of the key aspects to our race in allowing us to be so strong in the second stint, to go out on the Mediums and be one of the fastest on track for some of the laps. We managed to go from tenth all the way up to fifth, with three of those overtakes on the final two laps.

It was a race where I had to go forwards and not maintain my position like I had to last week. It was much more a race of attacking and overtaking, which was nice to do. Very happy for myself but even more for the team, and getting some more points on the board with also the fastest lap from Carlos.

A really good two weekends and a very good start to the season. We just need to try to maintain it into the next one.

Andreas Seidl, Team Principal: Second race in a row here in Austria and another good performance from the team and both drivers. Its great to see both cars finish in the points, confirming were making progress in the right direction.

We could see that both in dry and wet conditions we have a car that can fight with the competitors around us, which is obviously very encouraging moving forward. It will be very interesting to see if we can now carry this performance and momentum into Hungary and to other tracks with different characteristics.

We want to apologise to Carlos for the issue we had at his first pit-stop, which made his race more difficult than it shouldve been. The delay cost him several track positions and we sent him into heavy traffic, which ruined his tyres and didnt allow him to fight for the position he deserved to be in today.

Carlos didnt give up and did a great job securing the fastest lap, the second time in a row for us. Lando showed hes a fighter despite the pain he suffered during the weekend. He continued to perform and stepped up when it really mattered, especially in the second half of the race and again with some exciting final laps. Great teamwork between the two drivers swapping on track when it was needed.

Thank you again to Renault for ensuring we got the most out of our power unit and maximising our performance over the course of this weekend in varying weather conditions.

Tomorrow we start another race week. Well take away a lot of positives from these first two weekends, but at the same time well focus on all the areas we have to improve. As always, well use the time next week to analyse in detail what happened, try to learn from it and come back stronger in Budapest.

Well done to the FIA, F1 and the local promoter here in Austria, who allowed us to race again in the safest manner possible. Finally, a massive thank you to our partners and fans for their continued support, which has been incredible again despite not being able to be at the track with us.

Follow this link:

McLaren: Were making progress in the right direction - Grand Prix 247

Progress On Leading Health Care of Louisianas New $4.5M Home Office – Developing Lafayette

Posted on by

Last year, in October, we shared the news that Leading Health Care of Louisiana started construction on a new 4.5 million dollar m home office building, located at 206 La Rue Francejust off Pinhook Road.

You can read more about this in our initial post here: https://developinglafayette.com/wp/new-4-5m-home-office-building-to-house-lafayette-based-leading-health-care-of-louisiana/Rendering of the new facility provided by Lynn Guidry

Just the other day, we asked ourselves, what does this project look like now? It has been several monthsalmost a yearand you really arent able to see the building from Pinhook. So we decided to go check it out.

It appears that most of the steel structure is up and wall paneling will start to go up shortly if it hasnt already.

The building will be a two-story facility with approximately 20,000 square feet. The architect for the project is Lynn Guidry Architect from Carencro, and the general contractor is Master Builders & Specialists from Lafayette.

Tentative completion was set for the Summer of 2020, but with this global pandemic, the timeline appears to be pushed back some.

Read the original here:

Progress On Leading Health Care of Louisianas New $4.5M Home Office - Developing Lafayette